These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 30552587

  • 1. Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.
    Kamar N, Cassuto E, Piotti G, Govoni M, Ciurlia G, Geraci S, Poli G, Nicolini G, Mariat C, Essig M, Malvezzi P, Le Meur Y, Garrigue V, Del Bello A, Rostaing L.
    Adv Ther; 2019 Feb; 36(2):462-477. PubMed ID: 30552587
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effectiveness and safety of once-daily tacrolimus formulations in de novo liver transplant recipients: The PRETHI study.
    Bilbao I, Gómez Bravo MÁ, Otero A, Lladó L, Montero JL, González Dieguez L, Graus J, Pons Miñano JA.
    Clin Transplant; 2023 Dec; 37(12):e15105. PubMed ID: 37615653
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of Concentration/Dose Ratio in De Novo Kidney Transplant Recipients Receiving LCP-Tacrolimus or Immediate-Release Tacrolimus: Post Hoc Analysis of a Phase 3 Clinical Trial.
    Suwelack B, Bunnapradist S, Meier-Kriesche U, Stevens DR, Procaccianti C, Morganti R, Budde K.
    Ann Transplant; 2020 Jul 28; 25():e923278. PubMed ID: 32719307
    [Abstract] [Full Text] [Related]

  • 6. Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.
    Trofe-Clark J, Brennan DC, West-Thielke P, Milone MC, Lim MA, Neubauer R, Nigro V, Bloom RD.
    Am J Kidney Dis; 2018 Mar 28; 71(3):315-326. PubMed ID: 29162334
    [Abstract] [Full Text] [Related]

  • 7. Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe.
    Budde K, Rostaing L, Maggiore U, Piotti G, Surace D, Geraci S, Procaccianti C, Nicolini G, Witzke O, Kamar N, Albano L, Büchler M, Pascual J, Gutiérrez-Dalmau A, Kuypers D, Wekerle T, Głyda M, Carmellini M, Tisone G, Midtvedt K, Wennberg L, Grinyó JM.
    Transpl Int; 2022 Mar 28; 35():10225. PubMed ID: 36017158
    [Abstract] [Full Text] [Related]

  • 8. Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.
    Fernandez Rivera C, Calvo Rodríguez M, Poveda JL, Pascual J, Crespo M, Gomez G, Cabello Pelegrin S, Paul J, Lauzurica R, Perez Mir M, Moreso F, Perelló M, Andres A, González E, Fernandez A, Mendiluce A, Fernández Carbajo B, Sanchez Fructuoso A, Calvo N, Suarez A, Bernal Blanco G, Osuna A, Ruiz-Fuentes MC, Melilli E, Montero Perez N, Ramos A, Fernández B, López V, Hernandez D, Better study.
    Clin Transplant; 2022 Mar 28; 36(3):e14550. PubMed ID: 34851532
    [Abstract] [Full Text] [Related]

  • 9. Impact of Switching From Immediate- or Prolonged-Release to Once-Daily Extended-Release Tacrolimus (LCPT) on Tremor in Stable Kidney Transplant Recipients: The Observational ELIT Study.
    Giral M, Grimbert P, Morin B, Bouvier N, Buchler M, Dantal J, Garrigue V, Bertrand D, Kamar N, Malvezzi P, Moreau K, Athea Y, Le Meur Y.
    Transpl Int; 2024 Mar 28; 37():11571. PubMed ID: 38694490
    [Abstract] [Full Text] [Related]

  • 10. Bioavailability and costs of once-daily and twice-daily tacrolimus formulations in de novo kidney transplantation.
    Glander P, Waiser J, Kasbohm S, Friedersdorff F, Peters R, Rudolph B, Wu K, Budde K, Liefeldt L.
    Clin Transplant; 2018 Aug 28; 32(8):e13311. PubMed ID: 29888809
    [Abstract] [Full Text] [Related]

  • 11. A single-center, open-label, randomized cross-over study to evaluate the pharmacokinetics and bioavailability of once-daily prolonged-release formulations of tacrolimus in de novo liver transplant recipients.
    Herden U, Sterneck M, Buchholz BM, Achilles EG, Ott A, Fischer L.
    Immun Inflamm Dis; 2021 Dec 28; 9(4):1771-1780. PubMed ID: 34559956
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study.
    Tremblay S, Nigro V, Weinberg J, Woodle ES, Alloway RR.
    Am J Transplant; 2017 Feb 28; 17(2):432-442. PubMed ID: 27340950
    [Abstract] [Full Text] [Related]

  • 14. LCPT once-daily extended-release tacrolimus tablets versus twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroups.
    Bunnapradist S, Rostaing L, Alloway RR, West-Thielke P, Denny J, Mulgaonkar S, Budde K.
    Transpl Int; 2016 May 28; 29(5):603-11. PubMed ID: 26953629
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of a novel tablet formulation of tacrolimus and conventional capsule formulation in de novo kidney transplant recipients: a systematic review and meta-analysis.
    Liu Z, Yin K, Liu H, Wang N, Yao J, Zhou J, Tang Y, Yin Z.
    Front Pharmacol; 2023 May 28; 14():1310339. PubMed ID: 38143499
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial.
    Faravardeh A, Akkina S, Villicana R, Guerra G, Moten MA, Meier-Kriesche U, Stevens DR, Patel SJ, Bunnapradist S.
    Ann Transplant; 2021 Apr 16; 26():e929535. PubMed ID: 33859155
    [Abstract] [Full Text] [Related]

  • 18. MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients.
    Baccarani U, Velkoski J, Pravisani R, Adani GL, Lorenzin D, Cherchi V, Falzone B, Baraldo M, Risaliti A.
    Transplant Proc; 2019 Nov 16; 51(9):2971-2973. PubMed ID: 31607620
    [Abstract] [Full Text] [Related]

  • 19. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
    Staatz CE, Tett SE.
    Clin Pharmacokinet; 2015 Oct 16; 54(10):993-1025. PubMed ID: 26038096
    [Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetics of immediate- and prolonged-release tacrolimus formulations in liver, kidney and heart transplant recipients.
    Lu Z, Bonate P, Keirns J.
    Br J Clin Pharmacol; 2019 Aug 16; 85(8):1692-1703. PubMed ID: 30950096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.